Using Biomarkers to Identify and Treat Schizophrenia, University of California, San Diego (UCSD) Study

7/12/2012 8:07:25 AM

In the current online issue of PLoS ONE, researchers at the University of California, San Diego School of Medicine say they have identified a set of laboratory-based biomarkers that can be useful for understanding brain-based abnormalities in schizophrenia. The measurements, known as endophenotypes, could ultimately be a boon to clinicians who sometimes struggle to recognize and treat the complex and confounding mental disorder.

Read at ScienceDaily

Read at News Release

Read Article at

Related Companies

News Categories

• ScienceDaily

• News Release

• University of California, San Diego (UCSD)

• Diagnostics

• Medical Dev. & Diag. - Research